Various studies have been conducted on different aspects of colon cancer, including nodal staging, microsatellite markers, adjuvant chemotherapy duration, mutation analysis, and the efficacy of oxaliplatin-based therapy. These studies aim to improve treatment outcomes and predict recurrence in patients with stage II and III colon cancer.